Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma-2

<p><b>Copyright information:</b></p><p>Taken from "Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma"</p><p>BMC Cancer 2005;5():119-119.</p><p>Published online 20 Sep 2005</p><p>PMCID:PMC1266025.</p><p>Copyright © 2005 Lee et al; licensee BioMed Central Ltd.</p>and PC3 (P). (A) The immunoblot was incubated sequentially with antibodies specific to EphB4, α-actin and calnexin and exposed to autoradiographic film for the indicated times. MCF10A engineered to express EphB4 (5 μg protein lysate) was used as a positive control. The arrow indicates the expected size of each protein – 120 kDa for EphB4, 43.2 kDa for α-actin and 90 kDa for calnexin. The size of the marker proteins is shown on the left in kDa. (B) Coomassie stained duplicate gel for loading comparison